Sygnis SA (WSE:SYG)
Poland
· Delayed Price · Currency is PLN 1.515
-0.005 (-0.33%)
Last updated: Apr 29, 2026, 9:50 AM CET
Sygnis Revenue
In the year 2025, Sygnis had annual revenue of 11.34M PLN with 15.66% growth. Sygnis had revenue of 5.03M in the quarter ending December 31, 2025, with 50.82% growth.
Revenue
11.34M
Revenue Growth
+15.66%
P/S Ratio
4.29
Revenue / Employee
1.03M
Employees
11
Market Cap
48.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.34M | 1.53M | 15.66% |
| Dec 31, 2024 | 9.80M | -10.23M | -51.08% |
| Dec 31, 2023 | 20.03M | -8.48M | -29.73% |
| Dec 31, 2022 | 28.51M | 25.11M | 739.70% |
| Dec 31, 2021 | 3.39M | 600.08K | 21.47% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.41B |
| NEUCA | 13.64B |
| Synektik Spólka Akcyjna | 706.45M |
| Celon Pharma | 225.60M |
| Genomtec | 15.00K |
| Urteste | 1.80M |
| Read-Gene | 15.57M |
| BioMaxima | 59.11M |